Specific cancer pathways that were highly enriched for by our RelA targets include chronic myeloid leukemia, glioma, small cell lung cancer, pancreatic cancer. The gene discussed is RELA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.